(Q28337660)

2

0 references

R Bream

3

0 references

D Schreck

4

0 references

R Siddiqi

5

0 references

S H Rahimtoola

Journal of the American College of Cardiology

6

0 references

language of work or name

English

0 references

publication date

February 1987

0 references

published in

0 references

volume

9

0 references

issue

2

0 references

page(s)

389-97

0 references

cites work

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Quinidine-induced ventricular flutter and fibrillation without digitalis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Procainamide-lnduced polymorphous ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Ventricular tachycardia after disopyramide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Atypical ventricular tachycardia as a manifestation of disopyramide toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Disopyramide-induced ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

The arrhythmogenicity of antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Analysis of the spontaneous variability of ventricular arrhythmias: consecutive ambulatory electrocardiographic recordings of ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: implications for serial drug testing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Reproducibility of arrhythmia induction with intracardiac electrophysiologic testing: patients with clinical sustained ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: the importance of the type of ventricular arrhythmia induced and the number of premature stimuli required

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Role of triple extrastimuli during electrophysiologic study of patients with documented sustained ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Induction of clinical ventricular tachycardia using programmed stimulation: value of third and fourth extrastimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Programmed ventricular stimulation in survivors of an acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Frequency and significance of induced sustained ventricular tachycardia or fibrillation two weeks after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021

Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. B

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980394-7

7 January 2021